Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification.
about
Antimicrobial peptide defensin: identification of novel isoforms and the characterization of their physiological roles and their significance in the pathogenesis of diseasesRAGE: a new frontier in chronic airways diseaseCigarette smoke alters the secretome of lung epithelial cells.Outcome prediction in pneumonia induced ALI/ARDS by clinical features and peptide patterns of BALF determined by mass spectrometry.Protein profiles of bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.Sputum proteomics in inflammatory and suppurative respiratory diseasesDifferential gene expression in human conducting airway surface epithelia and submucosal glands.From proteomics to prescription-the search for COPD biomarkers.Application of proteomics and peptidomics to COPD.Proteomic profiling of peripheral blood neutrophils identifies two inflammatory phenotypes in stable COPD patients.Identification of differentially expressed proteins in blood plasma of control and cigarette smoke-exposed mice by 2-D DIGE/MS.Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patientsAirways disease: phenotyping heterogeneity using measures of airway inflammation.Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary diseaseSusceptibility to COPD: differential proteomic profiling after acute smokingPeptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases.Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometryAlcohol use disorders affect antimicrobial proteins and anti-pneumococcal activity in epithelial lining fluid obtained via bronchoalveolar lavage.Proteomic profiles in acute respiratory distress syndrome differentiates survivors from non-survivors.Expression of calgranulin A/B heterodimer after acute inhalation of endotoxin: proteomic approach and validation.Identification of oxidative stress related proteins as biomarkers for lung cancer and chronic obstructive pulmonary disease in bronchoalveolar lavage.Mass spectrometry-based proteomics in Chest Medicine, Gerontology, and Nephrology: subgroups omics for personalized medicine.Proteomic analysis of pure human airway gland mucus reveals a large component of protective proteins.Protein networks in induced sputum from smokers and COPD patients.Biomarkers in Exhaled Breath Condensate and Serum of Chronic Obstructive Pulmonary Disease and Non-Small-Cell Lung Cancer.The proteomics big challenge for biomarkers and new drug-targets discovery.Intriguing bronchoalveolar lavage proteome in a case of pulmonary langerhans cell histiocytosis.Protein composition of bronchoalveolar lavage fluid and airway surface liquid from newborn pigs.Protein tyrosine phosphatase 1B negatively regulates S100A9-mediated lung damage during respiratory syncytial virus exacerbations.Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers.Proteomic landscape of bronchoalveolar lavage fluid in human immunodeficiency virus infection.Biomarkers of lung-related diseases: current knowledge by proteomic approaches.Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?Proteomics of lung cell biology and pulmonary disease.Proteomics in detection and monitoring of asthma and smoking-related lung diseases.Chronic lung diseases.Significance of bioinformatics in research of chronic obstructive pulmonary disease.An omics strategy for discovering pulmonary biomarkers potentially relevant to the evaluation of tobacco products.DAMPs activating innate and adaptive immune responses in COPD.Pathophysiology of tobacco smoke exposure: recent insights from comparative and redox proteomics.
P2860
Q26865308-D8759CCB-DBE2-48B8-8B57-09B1EDD65448Q27025295-037F4053-FF02-4620-904C-70D4542D1995Q30395716-6516CE14-F05F-4CB7-AE0C-5F328588B1B6Q31032368-7726F134-1099-4362-8A7C-DA7C4FFC6FB4Q33232592-084C789E-A59F-4CA7-8FEF-141723464D93Q33345110-4D441D06-806D-45E7-A009-DC2182C1D9DDQ33360227-22527539-92C8-47B5-822E-BA725CC1D5BEQ33509146-7CB8B076-6DB9-4E11-9FF8-F7801220A282Q33634488-B8CB1456-FD77-42A2-90A0-1DD1EFB964D5Q33716738-C85B7306-E7A6-4BDC-B5CA-3F91A9BEEBDCQ33815416-3B64D362-D3EA-4322-A07E-600BB3C25D2CQ33815640-AFDA5F2D-1B90-434E-B362-96E5ACCB046FQ33864952-66D674C4-3F3C-4B32-A151-5750D39A0CE5Q33868579-EB9BD44B-23A4-4AF8-B3EA-836CEA5D8A7DQ33921450-2D3F9AA0-2FF8-4934-90A7-2C0F708A09E2Q33959602-AFE7F9C4-1748-4033-9062-A2DF7BC4BCE0Q34077576-492AD9AB-24E3-4E9D-A612-89478B0E2630Q34092339-D3B8770E-79EE-4353-BFB5-D3C05BC9E552Q34302302-FD0C101A-B86A-491B-8930-8ACDFE6CCDCEQ34478167-98E59996-86DA-406C-B706-C89458CCBF07Q34579409-032F11C9-5B8B-43D7-AA4D-0905DC7F55D0Q34691573-9C1A1D3F-1A77-43D7-965C-3FAF98703F8AQ35565801-D5C43EBF-9578-4E9D-8A2C-F9005831F3E0Q36078336-A02CECA5-7C77-4859-84EC-074D41DB66EBQ36112558-DEE8B802-217F-4DDA-B875-68377BF7BDB5Q36432402-C4B50061-71E5-4865-8363-E1F5D44468C1Q37024708-D22B7794-648A-44E9-B124-90DBB62FAFC4Q37094215-22E6A665-83A2-4143-9317-7F237D482A58Q37131583-C0B57E10-D749-44B5-B233-AF5026DFD414Q37304126-0FE86EFB-5C30-45FA-8B89-A9B353AFED14Q37576091-D5BB4022-1E50-42F0-9C7D-88F707F4DDAFQ37579765-B12EA776-08CE-42DD-A4E1-84969394CCA4Q37702279-69C44CBE-E91A-4EBE-A845-CF29B95EAA2CQ37754857-35BC0418-6FAF-41F0-8F26-845299219AAEQ37763933-A3AB2256-90AD-48D8-B686-F1F4CE4EE5C9Q37787966-15F4F973-1970-4F1F-A834-7CFE60355FA5Q37970140-01078841-A173-4D46-80C2-135DE03F7291Q38066244-B6690687-14EC-41D8-9D0B-6EEF350732BCQ38154796-6B1CBB31-50C9-4A28-9B55-5B8405370B1DQ38165872-0544ACEF-C54F-4DC0-919C-42CF3BC9E264
P2860
Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Proteomic study of human bronc ...... metric protein identification.
@ast
Proteomic study of human bronc ...... metric protein identification.
@en
type
label
Proteomic study of human bronc ...... metric protein identification.
@ast
Proteomic study of human bronc ...... metric protein identification.
@en
prefLabel
Proteomic study of human bronc ...... metric protein identification.
@ast
Proteomic study of human bronc ...... metric protein identification.
@en
P2093
P2860
P356
P1433
P1476
Proteomic study of human bronc ...... metric protein identification.
@en
P2093
Andreas Weith
Dietrich Merkel
Martin C Lenter
Peter Seither
P2860
P304
P356
10.1002/PMIC.200401180
P577
2005-07-01T00:00:00Z